Application of Polar H7 Heart Rate Sensor in assessment of heart rate and heart rate variability Original article

Main Article Content

Maria Zaborska
Piotr Sobieraj

Abstract

Introduction: Atrial fibrillation increases cardiovascular mortality and morbidity.


The study was aimed to determine the possibility of application of the Polar H7 Heart Rate Sensor in assessment of heart rate in people with sinus rhythm. Results will be used to construct an algorithm, which would detect a silent atrial fibrillation using the Polar H7 Heart Rate Sensor.


Materials and methods: This prospective analysis study was conducted in a group of 15 healthy individuals (8 females, 7 males) aged of 22 ± 1,3 years with sinus heart rhythm. Heart rate was recorded simultaneously with ECG (CNSystems, Medizintechnik, Graz, Austria) and H7 Heart Rate Sensor (Polar Electro, Kempele, Finland). One hundred and fifty 30-second-long intervals recorded by both devices were compared in the terms to the agreement of the heart rate and heart rate variability. Variability of heart rate was defined as a standard deviation. Bland-Altman statistics were used in the analysis.


Results: We found good agreement between ECG and Polar H7 in assessment of mean heart rate: bias 0.37 with limits of agreement: -1.66 to 2.40. Worse agreement was observed according to heart rate variability: bias 2.52 with limits of agreement: 0.59–5.54.


Conclusion: Polar H7 Heart Rate Sensor showed a good agreement with reference method determining an mean heart rate in 30 second-long intervals. In terms of assessment of heart rate variability good enough compliance was not observed. Polar H7 Heart Rate Sensor can be used to assess mean heart rate in people with sinus rhythm at rest.

Downloads

Download data is not yet available.

Article Details

How to Cite
Zaborska , M., & Sobieraj , P. (2018). Application of Polar H7 Heart Rate Sensor in assessment of heart rate and heart rate variability. Cardiology in Practice, 12(2), 32-36. Retrieved from https://journalsmededu.pl/index.php/kwp/article/view/1220
Section
Articles

References

1. Bjorck S., Palaszewski B., Friberg L., Bergfeldt L.: Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study. Stroke 2013; 44(11): 3103-3108.
2. Haim M., Hoshen M., Reges O. et al.: Prospective National Study of the Prevalence, Incidence, Management and Outcome of a Large Contemporary Cohort of Patients With Incident Non‐Valvular Atrial Fibrillation. J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis. 2015; 4(1): e001486. DOI: 10.1161/ JAHA.114.001486.
3. Benjamin E.J., Wolf P.A., D’Agostino R.B. et al.: Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98(10): 946-952.
4. Stewart S., Hart C.L., Hole D.J., McMurray J.J.V.: A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am. J. Med. 2002; 113(5): 359-364.
5. Andersson T., Magnuson A., Bryngelsson I.L. et al.: All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case – control study. Eur. Heart J. 2013; 34(14): 1061-1067.
6. Wolf P.A., Abbott R.D., Kannel W.B.: Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22(8): 983-988.
7. Krahn A.D., Manfreda J., Tate R.B. et al.: The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba follow-up study. Am. J. Med. 1995; 98(5): 476-484.
8. Kirchhof P., Benussi S., Kotecha D. et al.: 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS. Eur. Heart J. 2016. http://doi.org/10.1093/eurheartj/ehw210.
9. Vandenberk T., Stans J.: Clinical Validation of Heart Rate Apps: Mixed-Methods Evaluation Study. JMIR Mhealth Uhealth 2017; 5(8): e129.
10. Boudreaux B.D., Hebert E.P., Hollander D.B. et al.: Validity of Wearable Activity Monitors during Cycling and Resistance Exercise. Med. Sci. Sports Exerc. 2018; 50(3): 624-633.
11. Gamelin F.X., Baquet G., Berthoin S., Bosquet L.: Validity of the polar S810 to measure R-R intervals in children. Int. J. Sports Med. 2008; 29(2): 134-138.
12. Gamelin F.X., Berthoin S., Bosquet L.: Validity of the Polar S810 Heart Rate Monitor to Measure R-R Intervals at Rest. Med. Sci. Sports Exerc. 2006; 38(5): 887-893.
13. Nunan D., Jakovljevic D.G., Donovan G. et al.: Levels of agreement for RR intervals and short-term heart rate variability obtained from the Polar S810 and an alternative system. Eur. J. Appl. Physiol. 2008; 103(5): 529-537.
14. Plews D.J., Scott B., Altini M. et al.: Comparison of Heart-Rate-Variability Recording With Smartphone Photoplethysmography, Polar H7 Chest Strap, and Electrocardiography. Int. J. Sports Physiol. Performance 2017; 12(10): 1324-1328.
15. Giles D., Draper N., Neil W.: Validity of the Polar V800 heart rate monitor to measure RR intervals at rest. Eur. J. Appl. Physiol. 2016; 116(3): 563-571.
16. Porto L.G.G., Junqueira Jr L.F.: Comparison of Time-Domain Short-Term Heart Interval Variability Analysis Using a Wrist-Worn Heart Rate Monitor and the Conventional Electrocardiogram. Pacing Clin. Electrophysiol. 2009; 32(1): 43-51.
17. Radespiel-Tröger M., Rauh R., Mahlke C. et al.: Agreement of two different methods for measurement of heart rate variability. Clin. Auton. Res. 2003; 13(2): 99-102.
18. Vanderlei L.C.M., Silva R.A., Pastre C.M. et al.: Comparison of the Polar S810i monitor and the ECG for the analysis of heart rate variability in the time and frequency domains. Braz. J. Med. Biol. Res. 2008; 41: 854-859.
19. Weippert M., Kumar M., Kreuzfeld S. et al.: Comparison of three mobile devices for measuring R–R intervals and heart rate variability: Polar S810i, Suunto t6 and an ambulatory ECG system. Eur. J. Appl. Physiol. 2010; 109(4): 779-786.
20. Wallén M.B., Hasson D., Theorell T. et al.: Possibilities and limitations of the polar RS800 in measuring heart rate variability at rest. Eur. J. Appl. Physiol. 2012; 112(3): 1153-1165.